230 related articles for article (PubMed ID: 15304582)
1. Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy.
Walter U; Dressler D; Wolters A; Probst T; Grossmann A; Benecke R
Neurology; 2004 Aug; 63(3):504-9. PubMed ID: 15304582
[TBL] [Abstract][Full Text] [Related]
2. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
Walter U; Niehaus L; Probst T; Benecke R; Meyer BU; Dressler D
Neurology; 2003 Jan; 60(1):74-7. PubMed ID: 12525721
[TBL] [Abstract][Full Text] [Related]
3. Basal ganglia echogenicity in tauopathies.
Sadowski K; Serafin-Król M; Szlachta K; Friedman A
J Neural Transm (Vienna); 2015 Jun; 122(6):863-5. PubMed ID: 25204278
[TBL] [Abstract][Full Text] [Related]
4. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
5. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
[TBL] [Abstract][Full Text] [Related]
6. Transcranial sonography in atypical parkinsonism: How reliable is it in real clinical practice? A multicentre comprehensive study.
Alonso-Canovas A; Tembl Ferrairó JI; Martínez-Torres I; Lopez-Sendon Moreno JL; Parees-Moreno I; Monreal-Laguillo E; Pérez-Torre P; Toledano Delgado R; García Ribas G; Sastre Bataller I; Masjuan J; Martinez-Castrillo JC; Walter U
Parkinsonism Relat Disord; 2019 Nov; 68():40-45. PubMed ID: 31621617
[TBL] [Abstract][Full Text] [Related]
7. Substantia nigra echogenicity in progressive supranuclear palsy.
Ebentheuer J; Canelo M; Trautmann E; Trenkwalder C
Mov Disord; 2010 Apr; 25(6):773-7. PubMed ID: 20198715
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
10. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
[TBL] [Abstract][Full Text] [Related]
11. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
Scaravilli T; Tolosa E; Ferrer I
Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration.
Illán-Gala I; Nigro S; VandeVrede L; Falgàs N; Heuer HW; Painous C; Compta Y; Martí MJ; Montal V; Pagonabarraga J; Kulisevsky J; Lleó A; Fortea J; Logroscino G; Quattrone A; Quattrone A; Perry DC; Gorno-Tempini ML; Rosen HJ; Grinberg LT; Spina S; La Joie R; Rabinovici GD; Miller BL; Rojas JC; Seeley WW; Boxer AL
JAMA Netw Open; 2022 Apr; 5(4):e229588. PubMed ID: 35486397
[TBL] [Abstract][Full Text] [Related]
13. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
Walter U; Wittstock M; Benecke R; Dressler D
J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
[TBL] [Abstract][Full Text] [Related]
14. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
[TBL] [Abstract][Full Text] [Related]
15. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
[TBL] [Abstract][Full Text] [Related]
16. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
Koga S; Zhou X; Dickson DW
Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
[TBL] [Abstract][Full Text] [Related]
17. Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease.
Miyata M; Kakeda S; Toyoshima Y; Ide S; Okada K; Adachi H; Wang Y; Korogi Y
Neuroradiology; 2019 Nov; 61(11):1251-1259. PubMed ID: 31267152
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
[TBL] [Abstract][Full Text] [Related]
19. Transcranial sonography in movement disorders.
Bartova P; Skoloudik D; Bar M; Ressner P; Hlustik P; Herzig R; Kanovsky P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Dec; 152(2):251-8. PubMed ID: 19219216
[TBL] [Abstract][Full Text] [Related]
20. Substantia nigra in progressive supranuclear palsy, corticobasal degeneration, and parkinsonism-dementia complex of Guam: specific pathological features.
Oyanagi K; Tsuchiya K; Yamazaki M; Ikeda K
J Neuropathol Exp Neurol; 2001 Apr; 60(4):393-402. PubMed ID: 11305875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
